Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? (Q37313049)

19 August 2017

1 reference

title

Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option? (English)

1 reference

19 August 2017

Eugen Florin Georgescu

series ordinal

1

1 reference

PubMed ID

18972077

19 August 2017

language of work or name

English

0 references

publication date

1 November 2008

1 reference

19 August 2017

1 reference

19 August 2017

25

1 reference

19 August 2017

11

1 reference

19 August 2017

1141-1174

1 reference

https://scigraph.springernature.com/pub.10.1007/s12325-008-0110-2

19 August 2017

0 references

cites work

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Effect of nutritional state on the formation of a complex involving insulin receptor IRS-1, the 52 kDa Src homology/collagen protein (Shc) isoform and phosphatidylinositol 3'-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Pathogenesis and management issues for non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Lipid peroxidation and oxidant stress regulate hepatic apolipoprotein B degradation and VLDL production

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Macrophages, PPARs, and Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Inflammatory mechanisms in the regulation of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Insulin induces upregulation of vascular AT1 receptor gene expression by posttranscriptional mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Physiology and pathophysiology of the adipose tissue renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Downregulation of angiotensin II type 1 receptors during sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Inhibitory effect of angiotensin II receptor antagonist on hepatic stellate cell activation in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Telmisartan, an angiotensin II type 1 receptor blocker, inhibits advanced glycation end-product (AGE)-elicited hepatic insulin resistance via peroxisome proliferator-activated receptor-gamma activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

Angiotensin-II type 1 receptor interaction is a major regulator for liver fibrosis development in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-008-0110-2

10.1007/S12325-008-0110-2

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

18972077